Bayer has committed $150m to build a cell culture technology centre at its pharmaceutical development and manufacturing site in Berkeley, California, US. The new 40,000ft² single-use technology (SUT) biopharmaceutical manufacturing facility will support the development […]
Copenhagen-based Zealand Pharma has announced positive results from a Phase III confirmatory study investigating dasiglucagon in patients with severe hypoglycemia related to diabetes. Dasiglucagon, a solublue glucagon analogue, which may become first-in-class and mimics the […]
Magenta Therapeutics, a clinical-stage biotechnology company, announced that the company presented Phase 2 clinical data on its cell therapy, MGTA-456, at the annual meeting of the American Academy of Neurology in Philadelphia, Pennsylvania. MGTA-456 is […]
Chairman of the 2019 Biosimilars Conference, Michel Mikhail, International Expert Regulatory Affairs, Global Expert of Biosimilars, invites biosimilar experts to attend the next Biosimilars Conference, taking place in London. This year’s event will address regulatory […]
SMi reports: Registration is now open for the HPAPI USA conference, taking place in Boston on the 21st-22nd October 2019. The HPAPI global market is growing at an ever-increasing rate of CAGR at 8.6% that […]